Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Crushing, fracturing, and bending tests quantify hardness.

Measuring Tablet Hardness: A Primer

Thomson Reuters released a report that provides a view of the challenges facing companies entering the United States biosimilar drug market.

Report Previews Future of U.S. Biosimilar Market

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.

Orally Disintegrating Tablets

Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost.

Improving the Economics of Monoclonal Antibody Separation

New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.

Advances in Biodegradable Polymer Technologies Facilitate Sustained Release of Parenteral Drugs

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Global Vaccine Action plan maps out a strategy to increase access and R&D for vaccines.

Pharma Industry Participates in Vaccine Initiatives

Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at Catalent Pharma Solutions

Kate Achtien in an R&D scientist at SAFC. kate.achtien@SAFC.com

Applications of ZFN technology in biopharmaceutical cell-line engineering.

ZFN Technology Advances Biopharmaceutical Manufacturing

The rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms.

Intellectual Property Battles in Solid-State Chemistry

Solid-state chemistry is an important part of drug development, and public research is advancing the field.